Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLONAZEPAM vs LORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLONAZEPAM vs LORAZEPAM: Safety Overview

Metric CLONAZEPAM LORAZEPAM
Total FAERS Reports 39,463 33,404
Deaths Reported 8,488 6,187
Death Rate 21.5% 18.5%
Hospitalizations 12,506 15,431
Average Patient Age 46.0 yrs 49.8 yrs
% Female Patients 58.3% 60.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Advagen Pharma Ltd Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription